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1 SYNTHESIS: PAPER  
Abstract: Various condensation and ring closing reactions 
were used for the syntheses of 3-[(alkylamino)methylene]-6-
methyl-1H-pyridine-2,4-diones, bicyclic pyridinones, and 
tricyclic morpholinopyrones. For instance, 3-
(dialkylamino)methylene-6-methyl-1H-pyridine-2,4-diones 
were synthesized from the condensation of dialkylamines and 
3-formyl-4-hydroxy-6-methyl-2-pyridinone (17). 3-Formyl-4-
hydroxy-6-methyl-2-pyridinone (19), derived from 17, was 
used to construct a number of bicyclic pyridinones via a one-
pot Knoevenagal/intramolecular lactonization reaction.  
Tricyclic morpholinopyrones were assembled from a 
dialkylation reaction involving a dinucleophile, 3-amino-4-
hydroxy-6-methyl-2-pyrone, and a dielectrophile, trans-3,6-
dibromocyclohexene.  Depending on the reaction conditions, 
isomers of the tricyclic molecules can be selectively produced, 
and their chemical structures were unequivocally determined 
using single-crystal X-ray analyses and 2D COSY 
spectroscopy. The fluorescently active bicyclic pyridinone 
compounds show longer absorption (368 - 430 nm; maximum) 
and emission wavelengths (450 ~ 467 nm) than those of 7-
amino-4-methylcoumarin (AMC; abs,max = 350 nm; em = 430 
nm) suggesting these molecules, such as 3-(2-aminoacetyl)-7-
methyl-6H-pyrano[3,2-c]pyridine-2,5-dione (11), can be 
employed as fluorescence activity-based probes for tracing 
biological pathways. 
Key words: Dialkylation, fluorescence probes, heterocycles, 3-
substituted 7-methyl-6H-pyrano[3,2-c]pyridine-2,5-diones, 
tetrahydro-6H-2,10-dioxa-9-azaanthracen-1-ones.  
In an effort of finding new structures differed from the 
tricyclic pyrone pharmacophore,1,2 we investigated 
various mono- and bicyclic pyridinone and tricyclic 
morpholinopyridinone molecules that may possess 
bioactivity.1,2  Although several methods have been 
reported for the preparations of bicyclic pyridinones,3-
7 a method for the synthesis of tricyclic 
morpholinopyrones (such as 13 – 16; Figure 1) is not 
available.  Herein, we described a number of reactions 
including the coupling of 3-formyl-4-hydroxy-2-
pyridinone (19) with secondary amines to produce 
exocyclic enamines and with -sulfinyl, -sulfonyl, 
and -keto esters to afford bicyclic pyridinones, and 
ring closing reactions of 3-amino-4-hydroxy-2-
pyrones with trans-3,6-dibromocyclohexene to give 
tricyclic morpholinopyrones.  Bicyclic pyridinones 
possess strong fluorescence activity at wavelengths of 
450 ~ 467 nm, which are suitable for activity-based 
probes8 and activity-based proteomics studies.9  
Synthesis of 3-(Alkylamino)methylene-6-
methyl-1H-pyridine-2,4-diones 
In search of new heterocyclic molecules possessing 
biological activity, monocyclic pyridinones 1 – 7, 
bicyclic pyridinones 8 – 12, and tricyclic 
morpholinopyrones 13 - 16 were synthesized (Figure 
1).  Since the synthesis of a monocyclic pyridinone, 6-
methyl-3-phenylaminomethylidene-1H-pyridine-2,4-
dione (18), has been reported through a coupling 
reaction of 4-hydroxy-6-methyl-2-pyridinone (17), 
triethyl orthoformate, and aniline,4 we treated 
compound 17 with primary amines such as 
benzylamine and adenine separately under similar 
reaction conditions, and found that monocyclic 
pyridinones 1 and 3, respectively, formed in 68% and 
50% yields (Scheme 1).  In the case of adenine, the 
C6-primary amino function appears to react faster 
than the C9-secondary amino group.  In both cases a 
mixture of stereoisomers (Z and E at the enamine 
function) formed in an inseparable 1:4.5 ratio for 
compound 1 and a 1:2 ratio for compound 3, based on 
NMR spectral data.  The regiochemistry of compound 
3 was determined from its 2D COSY NMR spectrum 
in which the enamine C7H of the major isomer at 
9.55 (d, J = 12 Hz) correlates with C6’-NH at  
13.95 (d, J = 12 Hz) and that of the minor isomer at 
9.51 (d, J = 12.9 Hz) correlates with C6’-NH at  
12.82 (d, J = 12.9 Hz).  N1- and N9’-hydrogens of 3 
appear as broad singlets. However this three-
component coupling reaction appears to be applicable 
only with primary amines, when a secondary amine 
such as piperidine was used, under similar reaction 
conditions no condensation product, i.e., monocyclic 
pyridinone 4, was found.   
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Figure 1 Synthesized monocyclic pyridinones 1 - 7, bicyclic 
pyridinones 8 - 12, and tricyclic morpholinopyrones 13 - 16. 
To overcome this problem, we utilized 3-formyl-4-
hydroxy-6-methyl-2-pyridinone (19), which pre-
installed with an aldehyde function at the C3 of the 
pyridinone as our starting material, in a two-
component condensation reaction with various 
secondary amines (Scheme 1).  Aldehyde 19 was 
prepared according to a previously established 
synthetic route starting from pyridinone 174 as 
described in Scheme 1.   
H
N
O OH
O
4
5
6
7
H
1
3
NH
N NHMe
N NHPh
O NHCH2NH2Ph
N
N
N
H
N
NH2
H
N
NH O
O
H
H
N
OH
O
17 19
19
19
19
1919
19
aniline, CH(OEt)3
DMF, AcOH (3:1)
103oC, 1 h
(61% yield)
18
K2CO3
H2O, 100oC
(90% yield)
EtOH, 25oC
(65% yield)
EtOH, 25oC
(65% yield)
EtOH, 25oC
(93% yield)
EtOH, 25oC
(82% yield)
EtOH, 25oC
(75% yield)
EtOH, 90oC
(75% yield)
2
CH2NH2
19
EtOH, 25oC
(48% yield)
HO
1
CH2NH2Ph
17
CH(OEt)3
DMF, AcOH (3:1)
(68% yield)
317
adenine, CH(OEt)3
DMF, AcOH (3:1)
(50% yield)
 
Scheme 1 Synthesis of monocyclic pyridinones 1 - 7. 
The enamine intermediate 18, formed as a 4:1 mixture 
of E- and Z-isomers, was hydrolyzed using aqueous 
potassium carbonate at 100oC to provide aldehyde 19 
(90% yield).  The spectral data for aldehyde 19 are 
similar to those previously reported.4 Various 
monocyclic pyridinone enamines, 1 – 7, were 
synthesized in good to excellent yields by treating 
aldehyde 19 with primary and secondary amines in 
ethanol (Scheme 1).  Compounds 1, 2, and 4 - 7 could 
be obtained at room temperature by treating aldehyde 
19 with benzylamine, 4-hydroxybenzylamine, 
piperidine, N-methylpiperazine, N-phenylpiperazine, 
and morpholine, respectively, however, condensation 
with adenine to form compound 3 required an 
elevated temperature to achieve product formation.  
During the course of the reaction, compounds 1 – 6 
precipitated out from the ethanolic reaction solvent, 
which facilitated product formation and isolation, 
however, compound 7 remained soluble and hence 2 - 
3 equivalents of morpholine was necessary to drive 
product formation as well as a longer reaction time.  
The 1H NMR spectral data of compounds 4 - 7 show 
the presence of single stereoisomers and that of 
compounds 1 - 3 indicate two stereoisomers.  The 
stereochemistry of 4 – 7 was not determined.  Single 
crystals of the major stereoisomer of 1 could be grown 
by slow cooling and evaporation in ethanol.  An 
ORTEP diagram of compound 1 from a single-crystal 
X-ray analysis is shown in Figure 2, which 
unequivocally determined the E enamine double bond 
geometry of 1 (NMR spectrum of the single crystals 
confirms it to be the major stereoisomer). Selected 
bond lengths and bond angles of compounds 1, 13, 
and 16 derived from single-crystal X-ray analyses are 
listed in Table 1. 
 
Figure 2 An ORTEP drawing of a single-crystal X-ray structure of 
E-3-(benzylamino-methylene)-6-methyl-1H-pyridine-2,4-dione 
(1), CCDC Reg. No. 989745, having a molecular formula of 
C14H14N2O2, triclinic, space group of P1ത, Z=2, and R1 factor of 
0.0702.  
Synthesis of Bicyclic Pyridinones 
Aldehyde 19 proved to be a versatile scaffold4 through 
which to construct various bicyclic pyridinone 
structures by treating it with various doubly activated 
esters such as methyl -(phenylsulfinyl)acetate, 
methyl -(phenylsulfonyl)acetate, ethyl 3-oxo-3-
phenylpropanoate, -(N-Boc-amino)--ketoester 20,10 
and -ketoester 22 in refluxing ethanol, employing 
piperidine as a catalyst (Scheme 2). The mechanism 
by which compounds 8 - 12 are formed is expected to 
proceed via Knoevenagel condensation4 of the ester 
with aldehyde 19 followed by an intramolecular 
lactone formation.  Notably, the ester function is 
required to orient at the cis configuration with the 
phenolic OH group for the lactonization.  When one 
equivalent of piperidine was used, by-product, 4, 
formed predominantly.  The bicyclic pyridinones 8, 9, 
and 10 could be obtained in 69%, 81%, and 100% 
isolated yields, respectively, after filtration of the 
products out from the crude reaction mixtures or 
column chromatography on silica gel. The bicyclic 
pyridinone 11 containing an amino function in the side 
chain was obtained in 45% overall yield from the 
coupling of 19 and 2010 followed by removal of the 
Boc protecting group of 21 with trifluoroacetic acid 
(TFA).    
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Scheme 2 Synthesis of bicyclic pyridinones 8 - 12. 
Similarly, coupling of 19 and -ketoester 22 followed 
by Boc-deprotection gave compound 12. Compound 
22 was prepared by modifying the reported synthesis 
of compound 20.10 The amino function of 11 or 12 can 
condense with carboxylic acid group of various amino 
acids or peptides to generate fluorescence-active 
molecules. 
Synthesis of Tricyclic Morpholinopyrones 
Molecules containing tricyclic pyrone scaffolds have 
been synthesized in our laboratory and have been 
shown to possess strong cell protective action against 
oligomeric amyloid β peptide toxicity1,11 and anti-viral 
activity.2  To explore new structures, a tricyclic pyrone 
scaffold containing a nitrogen atom in the central ring 
(such as 13) would provide an additional hydrogen 
bond donor (N-H) capacity.  We therefore examined a 
two-component coupling reaction for the synthesis of 
tricyclic morpholinopyrones from dinucleophile, 3-
aminopyrone 23, and dielectrophile, trans-3,6-
dibromocyclohexene (25).12  The expeditious 
synthesis started from commercially available 4-
hydroxy-6-methylpyran-2-one which was converted 
into 3-aminopyrone 23 via a two-step process13 
involving the nitration of 4-hydroxy-6-methylpyran-2-
one at C-3 by nitric acid/sulfuric acid followed by 
reduction of the resulting nitro function to amine over 
hydrogen/palladium to provide 23 in 62% overall 
yield.  To examine the two-component ring-closing 
reactions, we first study N-protected pyrone 24.  
Aminopyrone 23 was capped with a t-butoxycarbonyl 
(Boc) protecting group to afford Boc-amino pyrone 24 
in 57% yield (Scheme 3).  Upon treatment of pyrone 
24 with 1 equivalent of sodium hydride followed by 
dibromide 25, Boc-tricyclic morpholinopyrone 27 
resulted in a 25% yield, and no other isomers were 
found (Table 3, Entry 1).  We envision that the initial 
step requires deprotonation of 24 with sodium hydride 
to form a pyrone oxy anion, which upon treatment 
with dibromide 25 supposedly forms O-alkylated 
intermediate 26. This O-alkylated intermediate 
undergoes ring closing reaction to give 27.  The Boc 
protecting group of 27 was readily removed using 
10% TFA in dichloromethane at 40oC to furnish 
tricyclic morpholinopyrone 13 in a quantitative yield.  
Only the cis-diastereomer, 13, was detected from the 
cyclization reaction and the stereochemistry was 
unequivocally determined through a single-crystal X-
ray analysis (Figure 3). Single crystals of tricyclic 
morpholinopyrone 13 were achieved by slow 
evaporation of a solution of 13 in ethanol.  The crystal 
structure shows that the tricyclic scaffold forms a cis-
fused ring junction upon cyclization and the double 
bond is situated between C7 and C8 implying a SN2’ 
reaction takes place from intermediate 26 with 
retention of configuration.  The two synclinal bridge 
head protons have a torsion angle of 48.1o.  
Dibromide 25 was prepared from a one-step double 
bromination of cyclohexene with 2 equiv. of N-
bromosuccinimide (NBS)14 and the trans-
stereochemistry was verified by comparing its 1H 
NMR spectral data with the literature values.12  We 
have also obtained a single-crystal X-ray structure of 
this compound which agrees with that reported.12 The 
presence of a double bond in the 6-membered 
carbocyclic ring of the tricyclic skeleton is significant 
because it allows for further modification of the 
tricyclic scaffold as demonstrated in Scheme 3.  The 
double bond of 27 was regioselectively hydroxylated 
by employing standard hydroboration/oxidation 
conditions to give 8-hydroxy tricyclic morpholino-
pyrone 28 as a single stereoisomer. The 
stereochemistry at C8 was assumed in that borane 
approaches the C7,8 double bond from the least 
hindered face (same side of C8a and C10a Hs).   
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Scheme 3 Synthesis of tricyclic morpholinopyrones 13 - 15. 
4 SYNTHESIS: PAPER  
 
Figure 3 An ORTEP drawing of a single-crystal X-ray analysis of 
3-methyl-5,8a,9,10a-tetrahydro-6H-2,10-dioxa-9-azaanthracen-1-
one (13). CCDC Reg. No. 989746, having a molecular formula of 
C12H13N1O3, monoclinic, space group of P21/c, Z = 4, and R1 
factor of 0.0538. 
The regiochemistry of the C8 hydroxyl function was 
assigned from the appearances of C(8)H at  3.34 ppm 
showing a triplet of doublet with J values of 10.5 and 
4.7 Hz, C(8a)H at  4.20 ppm showing a doublet of 
doublet with J values of 10.1 and 3.5 Hz, and 
C(10a)H at  4.40 ppm showing a quartet with J value 
of 3.1 Hz, suggesting C(8)H orients at the axial, 
C(8a)H at axial,  and C(10a)H at equatorial position 
based on the J values. The chemical shift assignments 
and couplings were supported from the 2D COSY, 
HMBC, and HSQC spectra of 28. The regiochemistry 
at C8 was further verified from the oxidation of 28 to 
ketone 15 using 2-iodoxybenzoic acid (IBX) in 
DMSO.  Only two alkanyl down-field hydrogens at  
5.20 (d, J = 4 Hz, C8aH) and 4.75 (q, J = 4 Hz, 
C10aH) ppm were found in the 1H NMR spectrum of 
15.  The Boc protecting group of 28 can be removed 
by 10% TFA in dichloromethane at 40oC to give 8-
hydroxy tricyclic morpholinopyrone 14. These results 
are encouraging because the alkene, hydroxyl and 
ketone functionalities provide a means for further 
structural modification of the tricyclic ring system 
making further synthesis of analogs possible. 
Intriguing differences were observed in the 
aforementioned double alkylation reaction for the 
formation of tricyclic morpholinopyrone scaffold.  A 
regioisomer of 27, 30, was found when a different 
protecting group, p-methoxybenzyl (PMB), was used 
(Scheme 4).  The PMB group was installed via a two-
step reductive amination procedure1 by treating 3-
amino pyrone 23 with p-anisaldehyde in methanol 
followed by sodium cyanoborohydride and acetic acid 
in ethanol to give 29 in 89% yield. Various reaction 
conditions were examined for the dialkylation 
reactions and results are summarized in Scheme 5 and 
Table 3. A single diastereomer of the olefin 
regioisomer 30 was resulted when treating 29 with 
dibromide 25 and triethylamine in 50% isolated yield 
(Table 3, Entry 5) after column chromatographic 
purification.  No other isomers were found.  When 
sodium hydride was used in place of triethylamine in 
the above double alkylation reaction, only 7% yield of 
30 was obtained (Entry 4). The PMB group was 
removed by 5% TFA in dichloromethane at 40oC to 
give tricyclic morpholinopyrone 16, which structure 
was unequivocally determined from a single-crystal 
X-ray analysis (Figure 4). 
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Scheme 4 Synthesis of tricyclic morpholinopyrone 16. 
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Scheme 5 Synthesis of tricyclic morpholinopyrones 27, 30 and 16. 
 
Figure 4 An ORTEP drawing of a single-crystal X-ray analysis of 
3-methyl-7,8a,9,10a-tetrahydro-8H-2,10-dioxa-9-azaanthracen-1-
one (16). CCDC Reg. No. 989747, having a molecular formula of 
C12H13N1O3, monoclinic, space group of P21/c, Z = 4, and R1 
factor of 0.0595. 
The tricyclic scaffold of 16 also formed a cis-fused 
ring junction upon cyclization and the two synclinal 
bridge head protons have a torsion angle of 44.2o.  Of 
interest is the position of the double bond which is 
now found between C5 and C6.  This suggests that the 
cyclization steps took place either via initial SN2 N-
alkylation of 29 with dibromide 25 followed by SN2’ 
nucleophilic substitution (with retention of 
configuration) by the hydroxyl function, or by initial 
SN2’ O-alkylation of 29 with dibromide 25 (with 
retention of configuration) followed by ring closing 
due to SN2 nucleophilic substitution (inversion) by the 
amine function.  We further discovered that pyrone 16 
can be synthesized in a single step (in a lower yield; 
Table 3, Entry 7) by the direct treatment of amine 23 
with dibromide 25 and triethylamine in DMF at 120oC 
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for 2 h without the PMB protection.  Table 3 
summarizes the reaction conditions that formed 
tricyclic morpholinopyrone scaffolds. The alkylation 
of Boc-protected pyrone 24 with 25 and potassium 
carbonate or triethylamine gave only 3% and 7% 
yield, respectively (Entries 2 and 3).  The protecting 
groups appear to affect the regiochemistry of the 
olefinic moiety of the tricyclic products.  The use of 
Boc as an amine protecting group resulted in C7,8 
double bond isomer, while an amine substituent (with 
or without PMB protecting group) gave the C5,6-
double bond isomer.  The strengths of the N-H 
acidities appear to affect the initial alkylation step, 
which resulted in different regioisomers.  Notably, no 
tricyclic product was found when amine 23 was 
treated with NaH or DBU and dibromide 25 (Entries 6 
and 9), and the use of other bases such as pyridine 
only produced trace amounts of 16 (Entry 8). 
 
One of our goals in the synthesis of bicyclic 
pyridinones is the construction of new fluorescence 
activity-based probes.8,9 Based on the reported 
bicyclic heterocycles,15 bicyclic pyridinones 8 – 12 
should be fluorescently active.  Indeed, Table 2 
summarized photophysical data from the UV 
absorption and fluorescence emission spectra of 8 – 
12 and 21 showing longer absorption and fluorescence 
emission wavelengths compare with those of 
commercially available 7-amino-4-methylcoumarin 
(AMC; ex = 351 nm; em = 430 nm; abs,max = 350 nm 
in ethanol), a widely used fluorescence probe.15 All 
five compounds possess similar fluorescence emission 
wavelengths, em, of 450 – 467 nm and quantum 
yields, F, ranging from 0.03 to 0.54.  Perylene was 
used as a standard for the calculation of quantum 
yields.16 The C3 electron-withdrawing group such as 
sulfoxide, sulfone, and ketone of the bicyclic 
pyridinone system contributes bathochromic and 
bathofluoric shifts in the absorption and fluorescence 
spectra, respectively. The extended conjugation 
contributed from the phenyl ring of ketone 10 leads to 
a longer emission wavelength of 467 nm than other 
measured compounds, and sulfone 9 possesses the 
highest quantum yield. 
 
One-pot condensations of 3-formyl-4-hydroxy-6-
methyl-2-pyridinone (19) with secondary amines 
afforded various 3-(dialkylamino)methylene-6-
methyl-1H-pyridine-2,4-diones and with -sulfinyl, 
-sulfonyl, and -keto esters gave bicyclic 
pyridinones, which can be used as fluorescence probes 
for biochemical research.  Moreover, one-pot 
dialkylation reactions of 3-amino-4-hydroxy-6-
methyl-2-pyrones with trans-3,6-dibromocyclohexene 
under various reaction conditions were investigated 
and different regioisomers can be selectively produced 
albeit in low yields.  Bioactivity of the newly 
synthesized monocyclic, bicyclic and tricyclic 
molecules will be evaluated and reported in due 
course. 
 
 
 
Table 1. Selected bond lengths and bond angles of compounds 1, 13, and 16 from single-crystal X-ray analyses.  
Compound 1 Compound 13 Compound 16 
Bond lengths, 
[Å]   
Bond angles, [°] Bond lengths, 
[Å] 
Bond angles, [°] Bond lengths, 
[Å] 
Bond angles, [°] 
N(1)-C(2), 
1.362(3) 
C(2)-N(1)-C(6), 
124.60(19) 
C(1)-O(12), 
1.2236(15) 
O(2)-C(1)-
C(9A), 
117.48(10) 
C(1)-O(12), 
1.2239(17) 
O(12)-C(1)-
O(2), 117.12(12) 
N(1)-C(6), 
1.386(3) 
O(17)-C(2)-
N(1), 119.57(19) 
C(1)-O(2), 
1.3749(15) 
C(3)-O(2)-C(1), 
122.73(10) 
C(1)-O(2), 
1.3757(17) 
C(1)-O(2)-C(3), 
122.99(11) 
C(2)-O(17), 
1.258(2) 
O(17)-C(2)-
C(3), 124.0(2) 
C(1)-C(9A), 
1.4283(16) 
C(3)-C(4)-
C(4A), 
119.39(11) 
C(1)-C(9A), 
1.4395(18) 
C(3)-C(4)-
C(4A), 
119.23(13) 
C(2)-C(3), 
1.446(3) 
N(1)-C(2)-C(3), 
116.38(19) 
O(2)-C(3), 
1.3686(15) 
C(7)-C(8)-
C(8A), 
123.73(12) 
O(2)-C(3), 
1.3764(17) 
C(6)-C(5)-
C(10A), 
123.20(14) 
C(3)-C(7), C(7)-C(3)-C(2), C(3)-C(4), N(9)-C(8A)- C(3)-C(4), C(5)-C(6)-C(7), 
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1.387(3) 116.65(19) 1.3446(17) C(8), 113.59(11) 1.3476(19) 123.53(13)
C(3)-C(4), 
1.448(3) 
C(5)-C(4)-C(3), 
116.64(19) 
C(4)-C(4A), 
1.4235(17) 
N(9)-C(8A)-
C(10A), 
108.92(10) 
C(4)-C(4A), 
1.4269(19) 
N(9)-C(8A)-
C(8), 113.03(13) 
C(4)-O(18), 
1.257(3) 
N(8)-C(7)-C(3), 
127.3(2) 
C(7)-C(8), 
1.3314(19) 
O(10)-C(10A)-
C(8A), 
111.68(10) 
C(5)-C(6), 
1.332(2) 
N(9)-C(8A)-
C(10A), 
110.16(11) 
C(7)-N(8), 
1.303(3) 
C(7)-N(8)-C(9), 
123.29(19) 
N(9)-C(9A), 
1.3955(16) 
C(5)-C(10A)-
C(8A), 
111.43(11) 
C(8A)-C(10A), 
1.533(2) 
C(9A)-N(9)-
C(8A), 
119.03(12) 
 
Table 2. Photophysical data for absorption (abs) and emission (em) of compounds 8 – 12 and 21 in methanol.  a Wavelengths of maximum 
absorption. b Extinction coefficient. c Wavelengths of fluorescence excitation. d Wavelengths of maximum fluorescence emission. e Fluorescence 
quantum yields were calculated by following the reported method16 from two independent experiments. f Data were obtained in cyclohexane due 
to solubility. g Literature quantum yield of perylene is 0.94 (in cyclohexane).16  
Compounds 8 9 10 11 12 21 Perylenef
abs (nm)a 368 385 381 427 430 393 436 
log (M-1cm-1)b 4.16 4.26 4.18 3.85 3.67 4.18 4.40 
ex (nm)c 380 380 380 380 380 380 380 
em (nm)d 450 450 467 450 458 460 439 
Fe 0.03 0.54 0.03 0.14 0.06 0.22 0.94g
 
Table 3. Reaction conditions and yields of the formation of tricyclic morpholinopyrones 27, 30, and 16. 
Entry R Conditions 27 (% yield) 30 (% yield) 16 (% yield) 
1 Boc 
(i) NaH, DMF; 
(ii) Et3N, CH3CN, 
      95oC, 8 h 
25 - - 
2 Boc 
K2CO3, DMF,  
90oC, 8 h 3 - - 
3 Boc 
Et3N, DMF, 80oC, 
3 h 7 - - 
4 PMB 
NaH, 
DMF/CH3CN 
(1:1), 80oC, 8 h 
- 7 - 
5 PMB 
Et3N, DMF,  
80oC, 2.5 h - 50 - 
6 H 
(i) NaH, DMF; 
(ii) Et3N, CH3CN, 
80oC, 8 h 
- - 0 
7 H 
Et3N, DMF, 
120oC, 2 h - - 13 
8 H 
Pyridine, DMF, 
120oC, 0.5 h - - 2 
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9 H 
DBU, DMF, 
120oC, 0.5 h - - 0 
 
  
  
  
  
  
  
  
  
  
All melting points are uncorrected. 1H NMR spectra 
(400 MHz) and 13C NMR spectra (100 MHz) were 
measured from a solution in CDCl3 or DMSO-d6. The 
chemical shift data for each signal on 1H NMR are 
given in units of  relative to TMS ( = 0) or CHCl3 ( 
= 7.26). For 13C NMR spectra, the chemical shifts are 
recorded relative to CDCl3 ( = 77.0) or DMSO ( = 
39.5). The E and Z assignment in 13C NMR spectral 
data are assumed and based on the signal intensities.  
Low-resolution mass spectra were taken from an API 
2000-triple quadrupole ESI-MS/MS mass 
spectrometer. High-resolution Mass spectra were 
obtained using a LCT Premier time of flight mass 
spectrometer.  IR spectra were measured directly in 
either solid or liquid form. UV-Vis absorption 
measurements were recorded on a Hewlett Packard 
8453 UV-VIS spectrometer and fluorescence emission 
spectra were recorded on a Jobin Yvon-spec 
fluoromax-2 fluorescence spectrometer.  The slits on 
the fluoromax-2 spectrometer were set at 2.5 nm and 
an integration time of 0.5 seconds was used 
throughout.  An excitation wavelength of 380 nm was 
used in all compounds to record fluorescence 
emission spectra, and emissions were observed from 
400 - 600 nm.  The fluorescence quantum yields were 
determined by following a procedure reported by 
Brouwer16 using perylene (F = 0.94 in cyclohexane) 
as the standard reference compound.  Perylene was 
chosen as the reference because it has an emission 
wavelength similar to compounds 8 – 12 thus 
allowing the same excitation wavelength (380 nm) to 
be used for all molecules.  Fluorescence emission 
spectra and UV-VIS absorption spectra for 
compounds 8 – 12, and 21 were recorded at 2 M and 
20 M, respectively, in methanol, and perylene 
recorded at 1 M and 10 M, respectively, in 
cyclohexane.  Refractive indices for methanol and 
cyclohexane were incorporated when calculating 
relative fluorescence quantum yields.16 X-ray crystal 
structure data sets were collected on a Bruker Kappa 
APEX II systems using MoK radiation. Data were 
collected using APEX2 software (APEXII v2009, 
Bruker Analytical X-ray Systems, Madison, WI). Data 
collection strategies were determined using COSMO 
(v1.60, 1999-2009, Bruker Analytical X-ray System, 
Madison, WI). Scan speed and scan width were 
chosen based on scattering power and peak rocking 
curves. All datasets were collected at -153 °C using an 
Oxford Cryostream low-temperature device. Unit cell 
constants and orientation matrix were improved by 
least-squares refinement of reflections threshold from 
the entire dataset. Integration was performed with 
SAINT (v7.60a, 1997 – 2008, Bruker Analytical X-
ray System, Madison, WI), using this improved unit 
cell as a starting point. Precise unit cell constants were 
calculated in SAINT from the final merged dataset. 
Lorenz and polarization corrections were applied. 
Multi-scan absorption corrections was performed with 
SADABS (v2008/1, Bruker Analytical X-ray System, 
Madison, WI). Data were reduced with SHELXTL 
(v2008/4, Bruker Analytical X-ray System, Madison, 
WI). The structures were solved in all cases by direct 
methods without incident. The molecules were fully 
ordered, no solvent was present, and no constraints or 
restraints were applied. Coordinates for N-H hydrogen 
atoms were allowed to refine. All other hydrogen 
atoms were located in idealized positions and were 
treated with a riding model. Refinement was 
continued to convergence using the recommended 
weighting scheme. 4-Hydroxy-6-methyl-2-pyridinone 
(17) and 4-hydroxy-6-methylpyran-2-one were 
purchased from Fisher Scientific and Sigma-Aldrich, 
respectively. All solvents were dried over appropriated 
drying chemical such as calcium hydride (for DMF), 
magnesium (for ethanol), or sodium and 
benzophenone (for THF) followed by distillation.  All 
low molecular weight amines were purified by 
distillation.  
3-Formyl-4-hydroxy-6-methyl-2-pyridinone (19).4 
A solution of 8.0 g (64 mmol) of 4-hydroxy-6-methyl-
2-pyridinone (17), 53 mL (0.32 mol) of triethyl 
orthoformate, and 5.8 mL (64 mmol) of aniline in 60 
mL of DMF and acetic acid (3:1) under argon was 
heated at 130 oC for 1 h.  The solution was cooled to 
25 oC, diluted with water (300 mL), and extracted four 
times with CH2Cl2 (100 mL each).  The organic layers 
were washed with brine and concentrated to dryness.  
To it, diethyl ether (200 mL) was added, cooled to 0 
oC, and the precipitated solid was collected by 
filtration, washed with diethyl ether, and dried under 
vacuum to give 8.9 g (61% yield) of 6-methyl-3-
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[(phenylamino)methylene]pyridine-2,4(1H,3H)-dione 
(18)4 as a 4:1 ratio of E- and Z-isomers. 1H NMR  
9.76 (bs, 1H, NH), 8.87 (d, J = 12.5 Hz, 1H, =CHN, 
minor isomer), 8.83 (d, J = 12.5 Hz, 1H, =CHN, 
major isomer), 7.45–7.25 (m, 5H), 5.67 (s, 1H, =CH, 
minor isomer), 5.64 (s, 1H, =CH, major isomer), 2.20 
(s, 3H, major isomer), 2.18 (s, 3H, minor isomer).  A 
solution of 2.0 g (8.7 mmol) of 18 and 40 g (0.29 mol) 
of K2CO3 in 800 mL of water was heated at 100oC for 
4 h, cooled to 25 oC, acidified with conc. HCl to pH 2, 
and extracted twice with CH2Cl2.  The combined 
organic layer was washed with brine, dried (MgSO4), 
and concentrated to give 19. 
19 
Yield: 1.2 g (90%); yellow solids; mp 256oC (dec.).4 
1H NMR (400 MHz, CDCl3):  = 13.71 (s, 1 H, NH), 
11.50 (bs, 1 H, OH), 10.08 (s, 1 H, CHO), 5.86 (s, 1 
H, =CH), 2.36 (s, 3 H). 
13C NMR (100 MHz, DMSO-d6):  = 193.3, 174.7, 
163.3, 157.1, 105.3, 97.7, 19.5. 
MS (ESI, MeOH): m/z = 176.1 ([M + Na+]). 
3-[(Benzylamino)methylene]-6-methyl-1H-
pyridine-2,4-dione (1); Typical procedure for the 
synthesis of compounds 1 – 7 
To a solution of compound 19 (1.31 mmol) in distilled 
ethanol (4 mL) under argon was added benzylamine 
(1.44 mmol), stirred at 25 oC for 24 h, and the reaction 
solution was diluted with hexane:ether (1:1).  The 
precipitated solid was collected by filtration, washed 
with hexane:ether (1:1), and dried under vacuum to 
yield pure compound 1. 
1 
Yield: 0.26 g (82%); yellow solids (a mixture of E and 
Z isomers in a ratio of 4.5:1); mp 219-221oC. 
 1H NMR (400 MHz. CDCl3, major E-isomer):  = 
9.69 (bs, 1 H), 8.45 (d, J = 12 Hz, 1 H), 8.38 (s, 1 H), 
7.23-7.45 (m, 5 H), 5.56 (s, 1 H), 4.65 (d, J = 4 Hz, 2 
H), 2.13 (s, 3 H). 
13C NMR (100 MHz, CDCl3, major E-isomer):  = 
185.0, 166.9, 160.7, 149.3, 135.5, 129,3, 128.7, 127.8, 
107.0, 102.5, 54.5, 20.0. 
MS (ESI, MeOH): m/z = 265.4 ([M + Na+]). 
HRMS-ESI: m/z [M + Na]+ calcd for C14H14N2O2Na: 
265.0953; found: 265.0946.   
3-[(4-Hydroxybenzylamino)methylene]-6-methyl-
1H-pyridine-2,4-dione (2) 
From 1.7 mmol of aldehyde 19 and 1.7 mmol of 4-
hydroxylbenzylamine in ethanol (2 mL), after stirring 
at 25 oC for 4 h, compound 2 was isolated. 
2 
Yield: 0.21 g (48%); yellow solids (a mixture of E and 
Z isomers in a ratio of 7:3); mp 222-225 oC. 
1H NMR (400 MHz, DMSO-d6):  = 12.07-12.19 (m, 
0.7H, E-isomer), 10.91-11.01 (m, 0.3 H, Z-isomer), 
10.27 (s, 1 H), 9.50 (s, 1 H), 8.29-8.36 (m, 1 H), 7.17 
(d, J = 7.4 Hz, 2 H), 6.76 (d, J = 7.4 Hz, 2 H), 5.30 (s, 
1 H), 4.54-4.61 (m, 2 H), 1.98 (s, 3 H). 
13C NMR (100 MHz, DMSO-d6):  = 183.5 (E), 180.3 
(Z), 166.9 (Z), 165.0 (E), 159.4 (E), 159.0 (Z), 157.1 
(E&Z), 149.5 (E), 149.0 (Z), 129.5 (E&Z), 127.3 (Z), 
127.1 (E), 115.5 (E&Z), 106.2 (Z), 105.1 (E), 101.5 
(E), 101.4 (Z), 52.1 (E&Z), 19.1 (E&Z). 
MS (ESI, MeOH): m/z = 281.3 ([M + Na]+). 
HRMS-ESI: m/z [M + H]+ calcd for C14H15N2O3: 
259.1083; found: 259.1107. 
6-Methyl-3-[(9H-purin-6-ylamino)methylene]-1H-
pyridine-2,4-dione (3) 
From 1.31 mmol of compound 19 and 1.31 mmol of 
adenine in ethanol (4 mL), after stirring at 90 oC for 
14 h, compound 2 was isolated. 
3 
Yield: 0.27 g (75%); yellow solids (a mixture of E- 
and Z-isomers in a 2:1 ratio); mp >300oC (not melt). 
1H NMR (400 MHz, CDCl3):  = 13.95 (d, J = 12.0 
Hz, 0.7 H, E isomer), 13.75 (bs, 1 H, NH of two 
isomers), 12.82 (d, J = 12.9 Hz, 0.3 H, Z isomer), 
10.80 (bs, 0.3 H, NH of Z isomer), 10.73 (bs, 0.7 H, 
NH of E isomer), 9.55 (d, J = 12.0 Hz, 0.7 H, E 
isomer), 9.51 (d, J = 12.9 Hz, 0.3 H, Z isomer), 8.69 
(s, 1 H, two isomers), 8.59 (s, 1 H, two isomers), 5.51 
(s, 0.7 H, E isomer), 5.48 (s, 0.3 H, Z isomer), 2.08 (s, 
2.1 H, E isomer), 2.07 (bs, 0.9 H, Z isomer). 
13C NMR (100 MHz, DMSO-d6):  = 193.3 (E&Z), 
185.1 (E&Z), 180.8 (E&Z), 174.7 (Z), 167.6 (E), 
153.5 (E), 152.4 (Z), 151.9 (E&Z), 150.4 (E), 149.7 
(Z), 146.8 (Z), 144.4 (E), 122.3 (Z), 106.5 (Z), 106.4 
(E), 105.1 (E&Z), 19.5 (E), 19.4 (Z). 
MS (ESI, MeOH): m/z = 292.9 ([M + Na]+). 
HRMS-ESI: m/z [M + Na]+ calcd for C12H10N6O2Na: 
293.0763; found: 293.0749. 
6-Methyl-3-piperidin-1-ylmethylene-1H-pyridine-
2,4-dione (4) 
From 1.31 mmol of compound 19 and 1.44 mmol of 
piperidine in ethanol (4 mL), after stirring at 25 oC for 
12 h, compound 4 was isolated as a single 
stereoisomer. 
4 
Yield: 0.19 g (65%); yellow solids; mp 250-252 oC. 
1H NMR (400 MHz, CDCl3):  = 9.64 (bs, 1 H), 8.21 
(s, 1 H), 5.52 (s, 1 H), 3.93 (bs, 2 H), 3.70 (bs, 2 H), 
2.10 (s, 3 H), 1.84 (bs, 6 H). 
13C NMR (100 MHz, CDCl3): δ = 182.0, 166.5, 161.3, 
148.1, 107.8, 101.7, 59.2, 54.7, 27.0, 26.6, 23.4, 19.6. 
MS (ESI, MeOH): m/z = 243.5 ([M + Na]+). 
HRMS-ESI: m/z [M + H]+ calcd for C12H17N2O2:  
221.1290; found: 221.1262. 
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6-Methyl-3-(4-methylpiperazin-1-ylmethylene)-1H-
pyridine-2,4-dione (5) 
From 1.31 mmol of compound 19 and 1.44 mmol of 
1-methylpiperazine in ethanol (4 mL), after stirring at 
25 oC for 12 h, compound 5 was obtained. 
5 
Yield: 0.29 g (93%); yellow solids; mp 216 oC (dec.). 
1H NMR (400 MHz, CDCl3):  = 9.41 (bs, 1 H), 8.22 
(s, 1 H), 5.53 (s, 1 H), 4.03-4.15 (m, 2 H), 3.71-3.82 
(m, 2 H), 2.54-2.72 (m, 4 H), 2.35 (s, 3 H), 2.11 (s, 3 
H). 
13C NMR (100 MHz, CDCl3):   = 194.2, 161.2, 
148.5, 107.9, 102.1, 100.0, 57.6, 55.4, 55.3, 53.6, 
45.8, 19.7. 
MS (ESI, MeOH): m/z = 258.4 ([M + Na]+). 
HRMS-ESI: m/z [M + Na]+ calcd for C12H17N3O2Na: 
258.1218; found: 258.1242. 
 6-Methyl-3-(4-phenylpiperazin-1-ylmethylene)-
1H-pyridine-2,4-dione (6) 
From 1.31 mmol of compound 19 and 1.60 mmol of 
1-phenylpiperazine in ethanol (4 mL), after stirring at 
25 oC for 12 h, compound 6 was obtained. 
6 
Yield: 0.29 g (75%); yellow solids; mp 201oC (dec.). 
1H NMR (400 MHz, DMSO-d6):  = 10.01 (s, 1 H, 
NH), 8.22 (s, 1 H, =CH), 7.25 (t, J = 8 Hz, 2 H), 7.00 
(d, J = 8 Hz, 2 H), 6.84 (t, J = 8 Hz, 1 H), 5.20 (s, 1 H, 
=CH), 4.12-4.09 (m, 2 H), 3.85-3.92 (m, 2 H), 3.42-
3.35 (m, 4 H), 1.95 (s, 3 H). 
13C NMR (100 MHz, CDCl3):  = 159.8, 150.1, 148.4, 
148.3, 129.0, 119.5, 115.9, 112.1, 106.1, 101.5, 56.0, 
52.3, 49.1, 48.8, 18.8. 
MS (ESI, MeOH): m/z = 320.2 ([M + Na]+). 
HRMS-ESI: m/z [M + H]+ calcd for C17H20N3O2: 
298.1556; found: 298.1570. 
6-Methyl-3-morpholin-4-ylmethylene-1H-pyridine-
2,4-dione (7) 
From 1.31 mmol of compound 19 and 2.60 mmol of 
morpholine in ethanol (4 mL), after stirring at 25 oC 
for 24 h, and crystallization of the crude product from 
ethyl acetate and diethyl ether (1:1), compound 7 was 
obtained. 
7 
Yield: 0.19 g (65%); yellow solids; mp 180–182 oC 
(dec.). 
1H NMR (400 MHz, CDCl3):  =8.71, (bs, 1 H), 8.23 
(s, 1 H), 5.53 (s, 1 H), 4.26-3.56 (m, 8 H), 2.11 (s, 3 
H). 
13C NMR (100 MHz, CDCl3):  = 161.0, 148.7, 130.2, 
118.7, 107.8, 102.3, 67.4, 67.2, 57.6, 54.3, 19.7. 
MS (ESI, MeOH): m/z = 223.2 ([M + H]+). 
HRMS-ESI: m/z [M + Na]+ calcd for C11H14N2O3Na: 
245.0902; found: 245.0892. 
3-Benzenesulfinyl-7-methyl-6H-pyrano[3,2-
c]pyridine-2,5-dione (8); Typical procedure for the 
synthesis of compounds 8 – 12 
To a solution of compound 19 (0.16 mmol) and 
methyl -(phenylsulfinyl)acetate (0.20 mmol) in dry 
ethanol (1 mL) under argon was added piperidine 
(0.01 mmol) and the mixture stirred at 80 oC for 48 h. 
The reaction mixture was cooled to 25 oC and 
concentrated on a rotary evaporator to give a solid 
which was washed with ether, suspended in CH2Cl2 (1 
mL), and filtered. The resulting solid was washed with 
CH2Cl2 twice and dried under vacuum to give 
compound 8. 
8 
Yield: 34 mg (69%); yellow solids; mp 281–283 oC. 
1H NMR (400 MHz, DMSO-d6):  = 12.43 (s, 1 H), 
8.36 (s, 1 H), 7.75-7.70 (m, 2 H), 7.52–7.50 (m, 3 H), 
6.30 (s, 1 H), 2.28 (s, 3 H). 
13C NMR (100 MHz, DMSO-d6): = 164.7, 160.1, 
156.0, 153.0, 142.8, 137.4, 132.0, 129.5, 127.2, 125.6, 
105.7, 96.7, 19.3. 
MS (ESI, MeOH): m/z = 324.2 ([M + Na]+). 
HRMS-ESI: m/z [M = Na]+ calcd for C15H11NO4SNa: 
324.0307; found: 324.0305. 
3-Benzenesulfonyl-7-methyl-6H-pyrano[3,2-
c]pyridine-2,5-dione (9) 
From 0.20 mmol of compound 19, 0.24 mmol of 
methyl -(phenylsulfonyl)acetate (0.235 mmol) and 
0.01 mmol of piperidine in ethanol (1 mL), after 
stirring at 80 oC for 48 h, compound 9 was obtained. 
9 
Yield: 50 mg (81%); yellow solids; mp >300 oC (not 
melt). 
1H NMR (400 MHz, DMSO-d6):  = 12.41 (s, 1 H), 
8.66 (s, 1 H), 8.00 (d, J = 7.5 Hz, 2 H), 7.70 (t, J = 7.5 
Hz, 1 H), 7.60 (t, J = 7.5 Hz, 2 H), 6.33 (s, 1 H), 2.31 
(s, 3 H). 
13C NMR (100 MHz, DMSO-d6):  = 167.6, 160.8, 
156.5, 155.1, 145.7, 139.5, 134.8, 129.9, 129.1, 121.6, 
105.6, 97.5, 20.3. 
MS (ESI, MeOH): m/z = 340.4 ([M + Na]+). 
HRMS-ESI: m/z [M + Na]+ calcd for C15H11NO5SNa: 
340.0256; found: 340.0246. 
3-Benzoyl-7-methyl-6H-pyrano[3,2-c]pyridine-2,5-
dione (10) 
From 0.65 mmol of compound 19, 0.98 mmol of ethyl 
3-oxo-3-phenylpropanoate, and 0.03 mmol of 
piperidine in ethanol (3 mL), after stirring at 80 oC for 
48 h, compound 10 was obtained. 
10 
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Yield: 0.18 g (100%); yellow solids; mp 312–314 oC 
(dec.). 
1H NMR (400 MHz, DMSO-d6):  = 12.23 (bs, 1 H), 
8.15 (s, 1 H), 7.84 (d, J = 7.5 Hz, 2 H), 7.66 (t, J = 7.5 
Hz, 1 H), 7.53 (t, J = 7.5 Hz, 2 H), 6.33 (s, 1 H), 2.32 
(s, 3 H). 
13C NMR (100 MHz, DMSO-d6):  = 191.3, 165.6, 
160.3, 157.5, 153.4, 143.6, 136.7, 133.3, 129.3, 128.5, 
120.5, 105.2, 96.8, 19.4. 
MS (ESI, MeOH): m/z = 304.1 ([M + Na]+). 
HRMS-ESI: m/z [M = Na]+ calcd for C16H11NO4Na: 
304.0586; found: 304.0586.   
3-(2-Aminoacetyl)-7-methyl-6H-pyrano[3,2-
c]pyridine-2,5-dione (11) 
From 0.99 mmol of compound 19, 1.5 mmol of 4-tert-
butoxycarbonylamino-3-oxo-butyric acid ethyl ester 
(20),10 and 0.05 mmol of piperidine in ethanol (3 mL), 
after stirring at 70 oC for 48 h, and column 
chromatographic purification on silica gel using 
CH2Cl2:MeOH (15:1) as eluent, 21 was obtained. 
21 
Yield: 0.15 g (45%); colorless oil. 
1H NMR (400 MHz, DMSO-d6):  = 12.29 (s, 1 H), 
8.50 (s, 1 H), 7.69–7.70 (bs, 1 H), 6.34 (s, 1 H), 4.32 
(d, J = 5.9 Hz, 2 H), 2.32 (s, 3 H), 1.39 (s, 9 H). 
13C NMR (100 MHz, DMSO-d6):  = 192.3, 166.4, 
160.4, 158.3, 155.8, 155.0, 144.6, 117.1, 105.5, 96.7, 
78.0, 49.8, 28.2, 19.5. 
MS (ESI, MeOH): m/z = 357.3 ([M + Na]+). 
HRMS-ESI: m/z [M + Na]+ calcd for C16H18N2O6Na: 
357.1057; found: 357.1066. 
A solution of 21 (0.024 mmol) in 1 mL of 10% 
TFA/CH2Cl2 was stirred at 25 oC for 8 h. The solvent 
was removed under vacuo and the remaining solid 
kept under high vacuum to yield compound 11.  
11 
Yield: 8 mg (100%); yellow solids; mp 310 oC (dec.). 
1H NMR (400 MHz, DMSO-d6):  = 12.39 (bs, 1 H), 
8.58 (s, 1 H), 8.10–8.20 (bs, 2 H), 6.35 (s, 1 H), 4.32 
(s, 2 H), 2.30 (s, 3 H). 
13C NMR (100 MHz, DMSO-d6):  = 187.9, 165.7, 
159.2, 157.1, 155.1, 144.2, 114.5, 104.5, 95.7, 46.4, 
18.5. 
MS (ESI, MeOH): m/z = 235.2 ([M + H]+). 
HRMS-ESI: m/z [M + H]+ calcd for C11H11N2O4: 
235.0719; found: 235.0728. 
Ethyl 4-[N-(tert-butoxycarbonyl)-N-(4-(tert-
butoxycarbonyloxybenzyl)amino-3-oxobutanoate 
(22) 
To a cold (0 oC) solution of 4-(aminomethyl)phenol 
(40.6 mmol) and triethylamine (40.6 mmole) in THF 
(50 mL) under argon was added methyl 2-
bromoacetate (28.4 mmol) dropwise, and the solution 
was stirred at 25 oC for 12 h, concentrated, and 
column chromatographed on silica gel using a mixture 
of CH2Cl2 and MeOH (9:1) as eluant to give methyl 
N-(4-hydroxybenzylamino)acetate.17  
Yield: 3.6 g (45% yield); off-white solids; mp 105-107  
oC. 
1H NMR (400 MHz, DMSO-d6): δ = 9.25 (bs, 1 H, 
OH), 8.30 (s, 1 H, NH), 7.10 (d, J = 7.5 Hz, 2 H), 6.70 
(d, J = 7.5 Hz, 2 H), 3.60 (s, 3 H), 3.55 (s, 2 H), 3.24 
(s, 2 H). 
13C NMR (100 MHz, CDCl3): δ = 172.7, 155.4, 130.2, 
129.8, 115.5, 52.7, 51.9, 49.5. 
MS (ESI, MeOH): m/z = 218.1 ([M + Na]+). 
To a solution of methyl N-(4-
hydroxybenzylamino)acetate (5.31 mmol) in 5 mL of 
p-dioxane and H2O (9:1), NaHCO3 (11.6 mmol) was 
added and the mixture was stirred at 25 oC for 5 
minutes. To it, di-tert-butyl dicarbonate (11.6 mmol) 
was added, and the solution was stirred for 12 h, 
diluted with brine (40 mL), and extracted four times 
with CH2Cl2 (100 mL each). The combined organic 
layer was washed with water and brine, dried 
(anhydrous Na2SO4), concentrated, and column 
chromatographed on silica gel using a mixture of 
CH2Cl2 and MeOH (20:1)  as eluant to give methyl N-
(4-hydroxybenzyl)-N-(tert-butoxycarbonyl)amino-
acetate. 
Yield: 1.19 g (76%); colorless oil. 
1H NMR (400 MHz, CDCl3) (indicating two 
rotamers):  = 7.07-7.05 (m, 2 H), 6.82-6.77 (m, 2 H), 
6.47-6.45 (bs, 1 H), 4.45 & 4.42 (2 s, 2 H), 3.90 & 
3.78 (2 s, 2 H), 3.71 & 3.68 (2 s, 3 H), 1.49 & 1.47 (2 
s, 9 H). 
MS (ESI, MeOH): m/z = 318.3 ([M + Na]+). 
To a solution of methyl N-(4-hydroxybenzyl)-N-(tert-
butoxycarbonyl)aminoacetate (4.03 mmol) in 2 mL of 
dioxane and H2O (1:1), NaOH (12.1 mmol) was 
added.  The solution was stirred at 25 oC for 2h, 
neutralized with 1 N HCl to pH 6, and concentrated to 
dryness leaving a white solid.  The solid was 
dissolved in 5 mL of dry DMF under argon, and NaH 
(8.11 mmol) and di-tert-butyl dicarbonate (4.87 
mmol) were added.  The solution was stirred at 25 oC 
for 12 h, diluted with water, and extracted with ethyl 
acetate twice (100 mL each). The combined organic 
layer was washed with brine, dried (anhydrous 
Na2SO4), concentrated to give N-(4-tert-
butoxycarbonylbenzyl)-N-(tert-butoxycarbonyl)-
aminoacetic acid. 
Yield: 1.56 g (84%); colorless oil. 
1H NMR (400 MHz, CDCl3) (2 rotamers): δ = 7.28-
7.22 (m, 2 H), 7.14-7.11 (m, 2 H), 4.53-4.49 (m, 2 H), 
3.94-3.80 (m, 2 H), 1.55-1.52 (m, 9 H), 1.48-1.47 (m, 
9 H). 
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13C NMR (100 MHz, CDCl3) (2 rotamers): δ = 
174.58, 174.57, 155.5, 155.4, 151.6, 150.3, 134.5, 
134.4, 128.9, 128.2, 121.2, 83.3, 81.0, 80.8, 50.8, 
50.2, 47.5, 28.1, 28.0, 27.4. 
MS (ESI, MeOH; negative ion mode): m/z = 380.5 
([M – H]-). 
To a solution of N-(4-tert-butoxycarbonylbenzyl)-N-
(tert-butoxycarbonyl)aminoacetic acid (4.09 mmol) in 
dry THF (4 mL) under argon was added 1,1’-
carbonyldiimidazole (4.44 mmol). The solution was 
stirred at 25 oC for 4 h to give the corresponding acyl 
imidazole. To a mixture of 0.54 g (5.65 mmol) of 
MgCl2 and 0.71 g (5.36 mmol) of monoethyl malonate 
potassium salt under argon, 0.85 mL (6.14 mmol) of 
triethylamine and 2 mL of THF were added. The 
solution was stirred at 25 oC for 4 h, and the above 
acyl imidazole solution was added via cannula.  The 
resulting reaction mixture was stirred at 25 oC for 18 
h, diluted with H2O and 0.1 M HCl to pH = 5, and 
extracted three times with ethyl acetate.  The 
combined organic layer was washed with aqueous 
NaHCO3, and brine, dried (anhydrous Na2SO4), 
concentrated, and column chromatographed on silica 
gel using a mixture of hexane and  EtOAc (15:1) as 
eluant to give compound 22. 
22 
Yield: 0.66 g (36%); colorless oil. 
1H NMR (400 MHz, CDCl3) (2 rotamers): δ = 7.28-
7.20 (m, 2 H), 7.14–7.12 (m, 2 H), 4.49–4.45 (m, 2 
H), 4.17 (q, J = 7.2 Hz, 2 H), 4.07 & 3.93 (2 s, 2 H; 2 
rotamers), 3.42 & 3.35 (2 s, 2 H; 2 rotamers), 1.56 (s, 
9 H), 1.47 (s, 9 H), 1.26 (t, J = 7.2 Hz, 3 H). 
13C NMR (100 MHz, CDCl3) (2 rotamers): δ = 198.8, 
198.6, 166.8, 166.6, 155.6, 155.3, 151.8, 150.5, 150.4, 
134.9, 134.8, 129.2, 128.5, 121.4, 83.6, 80.9, 61.5, 
55.8, 55.4, 51.0, 50.5, 46.4, 46.2, 28.3, 28.1, 27.64, 
27.59, 14.0. 
MS (ESI, MeOH): m/z = 474.5 ([M + Na]+). 
HRMS-ESI: m/z [M + Na]+ calcd for C23H33NO8Na: 
474.2098; found: 474.2087. 
3-[2-(4-Hydroxybenzylamino)acetyl]-7-methyl-6H-
pyrano[3,2-c]pyridine-2,5-dione (12) 
To a solution of compound 19 (1.22 mmol) and 22 
(1.22 mmol) in ethanol (8 mL) under argon was added 
piperidine (0.05 mmol), and the reaction mixture was 
stirred at 70 oC for 48 h. It was cooled to 25 oC, 
diluted with ether (10 mL), and the solid was collected 
by filtration and purified by column chromatography 
on silica gel using CH2Cl2:MeOH (15:1) as an eluant 
to give the N-Boc derivative of 12. 
Yield: 0.26 g (41%); yellow solids; mp 188-190 oC. 
1H NMR (400 MHz, CDCl3) (2 rotamers):  = 12.87 
& 12.80 (2 bs, 1 H NH, for two rotamers), 8.85 & 
8.83 (2 s, 1 H, =CH), 7.27-7.25 (m, 2 H, Ar), 7.13-
7.09 (m, 2 H, Ar), 6.16 & 6.14 (2 s, 1 H, =CH), 4.62 
(s, 1 H, CH2N of one rotamer), 4.53 (bs, 2 H, CH2N), 
4.50 (s, 1 H, CH2N of one rotamer), 2.47 and 2.45 (2 
s, 3 H, two rotamers), 1.54 and 1.53 (2 s, 9 H, t-Bu, 
two rotamers), 1.45 and 1.41 (2 s, 9 H, two rotamers). 
13C NMR (100 MHz, CDCl3) (2 rotamers):  = 191.7, 
191.6, 166.7, 162.6, 158.2, 155.8, 153.6, 153.5, 151.8, 
150.2, 145.6, 135.4, 135.2, 128.9, 128.3, 121.2, 118.5, 
118.3, 105.8, 98.3, 83.5, 80.5, 80.2, 56.3, 56.2, 51.5, 
50.6, 28.3, 28.2, 27.6, 20.0. 
MS (ESI, MeOH): m/z = 563.7 ([M + Na]+). 
The above solid (0.10 mmol) was dissolved in 20% 
TFA/CH2Cl2 (1 mL) and stirred at 25 oC for 30 min. 
The solvent was removed under a rotary evaporator 
and the remaining solid kept under high vacuum to 
yield compound 12. 
12 
Yield: 34 mg (100% yield); yellow solids (a TFA salt); 
mp 180–181 oC (dec.). 
1H NMR (400 MHz, DMSO-d6):  = 12.42 (bs, 1 H), 
9.69 (bs, 1 H), 9.15 (bs, 1 H), 8.61 (s, 1 H), 7.31 (d, J 
= 8.6 Hz, 2 H), 6.80 (d, J = 8.6 Hz, 2 H), 6.40 (s, 1 H), 
4.46 (s, 2 H), 4.10 (s, 2 H), 2.34 (s, 3 H). 
13C NMR (100 MHz, DMSO-d6):  = 188.3, 169.5, 
165.0, 158.2, 157.0, 154.1, 137.3, 129.6, 121.5, 115.5, 
114.5, 105.5, 96.9, 53.7, 45.6, 18.9. 
MS (ESI, MeOH): m/z = 341.4 ([M + H]+). 
HRMS-ESI: m/z [M + Na]+ calcd for C18H16N2O5Na: 
363.0957; found: 363.0981. 
3-Amino-4-hydroxy-6-methylpyran-2-one (23)13 
To a cold (0 oC) solution of 4-hydroxy-6-methyl-2H-
pyrone (79.3 mmol) in H2SO4 (25 mL) was added 
drop wise a mixture of H2SO4 (4.23 mL) and HNO3 
(119 mmol) over 10 min. After stirring for 30 min, the 
reaction mixture was poured into ice water, and the 
precipitate was collected by filtration, washed with 
cold water (3 times) and dried under vacuum to give 
4-hydroxy-6-methyl-3-nitropyran-2-one. 
Yield: 10.7 g (79%); white solids; mp 163-166 oC 
(lit.18 165 oC). 
IR (solid form): 1748, 1639, 1530, 1215, 1194, 1086, 
996, 827, 783 cm-1. 
1H NMR (400 MHz, CDCl3): δ = 11.21 (bs, 1 H, OH), 
6.14 (s, 1 H, ＝CH), 2.37 (s, 3 H, CH3). 
13C NMR (100 MHz, DMSO-d6): δ = 166.4, 165.4, 
156.6, 119.5, 100.7, 19.8. 
MS (ESI, MeOH, negative ion mode): m/z = 170.4 
([M – H]-). 
A solution of 4-hydroxy-6-methyl-3-nitropyran-2-one 
(2.0 g, 11.7 mmol) and 10% palladium on carbon (0.2 
g) in MeOH (30 mL) was stirred under 1 atmosphere 
of hydrogen at 25 oC for 18 h.  The reaction mixture 
was filtered and concentrated to give compound 23.13 
23 
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Yield: 1.33 g (80%); brown solids; mp 198–200 oC. 
1H NMR (400 MHz, DMSO-d6): δ = 6.31 (s, 1 H, ＝
CH), 3.80 (bs, 3 H, NH2, OH), 2.22 (s, 3 H, CH3). 
13C NMR (100 MHz, DMSO-d6): δ = 161.7, 153.5, 
119.6, 104.4, 103.3, 18.9. 
MS (ESI, MeOH): m/z = 164.1 ([M + Na]+). 
tert-Butyl (4-hydroxy-6-methyl-2-oxo-2H-pyran-3-
yl)carbamate (24) 
To a hot (85 oC) solution of 3-amino-4-hydroxy-6-
methyl-pyran-2-one (23, 1.28 mmol) in 5 mL of 
acetonitrile under argon was added di-tert-butyl 
dicarbonate (2.46 mmol) in portion wise over a period 
of 6 h.  The reaction solution was cooled and 
concentrated on a rotary evaporator to give an oil, 
which was purified by flash chromatography on silica 
gel eluting with hexane/ethyl acetate (gradient elution) 
to yield compound 24. 
24 
Yield: 0.18 g (57%); white solids; mp 87–89 oC. 
1H NMR (400 MHz, CDCl3): δ = 12.08 (s, 1 H, OH), 
7.05 (s, 1 H, NH), 5.88 (s, 1 H, ＝CH), 2.21 (s, 3 H, 
CH3), 1.50 (s, 9 H, tert-butyl). 
13C NMR (100 MHz, CDCl3): δ = 162.3, 156.7, 156.6, 
155.1, 103.6, 102.8, 83.7, 28.2, 19.4. 
MS (ESI, MeOH): m/z = 264.0 ([M + Na]+). 
HRMS-ESI: m/z [M + Na]+ calcd for C11H15NO5Na: 
264.0848; found: 264.0831. 
 tert-Butyl (8aS*,10aR*)-3-methyl-1-oxo-5,6,8a,10a-
tetrahydro-1H-2,10-dioxa-9-azaanthracene-9-
carboxylate (27) 
To a cold (0 oC) mixture of sodium hydride (0.25 
mmol) in dry DMF (1 mL) under argon was added 
compound 24 (0.25 mmol), and stirred at 25 oC for 30 
min.  The reaction solution was again cooled to 0 oC 
and a solution of trans-3,6-dibromocyclohexene (25; 
0.3 mmol) in dry DMF (1 mL) was added via cannula, 
and stirred at 25 oC for 18 h.  To it, were added dry 
acetonitrile (10 mL) and triethylamine (0.25 mmol), 
and the solution was heated at 95 oC for 8 h.  The 
reaction mixture was diluted with water (20 mL) and 
extracted with ethyl acetate (50 mL), and the organic 
layer was washed with brine (20 mL), dried (MgSO4), 
concentrated, and column chromatographed on silica 
gel using a mixture of hexane:ethyl acetate (1:1) as 
eluant to give compound 27. 
27 
Yield: 20 mg (25%); white solids; mp 129–130 oC. 
1H NMR (400 MHz, CDCl3): δ = 5.78-5.71 (m, 1 H, 
C8H), 5.72 (s, 1 H, C4H), 5.35–5.25 (m, 1 H, C7H), 
5.05–4.9 (m, 1 H, C8aH), 4.55–4.50 (m, 1 H C10aH), 
2.25-1.85 (m, 4 H), 2.19 (s, 3 H, CH3), 1.50 (s, 9 H, t-
Bu). 
13C NMR (100 MHz, CDCl3): δ = 160.5, 159.1, 157.3, 
153.4, 131.6, 123.9, 102.5, 99.4, 82.2, 74.5, 48.6, 
28.4, 25.9, 19.9, 19.5. 
2D-COSY NMR (acetone-d6, the use of acetone d6 as 
a solvent has changed the chemical shifts slightly 
from that of CDCl3): signal C10aH (δ 4.57) correlates 
with signal C8aH (δ 5.04), signal C8aH (δ 5.04) 
correlates with signal C8H (δ 5.78-5.71), and signal 
C8H correlates with signal C7H (δ 5.29). 
MS (ESI, MeOH): m/z = 342.3 ([M + Na]+). 
HRMS-ESI: m/z [M + Na]+ calcd for C17H21NO5Na: 
342.1317; found: 342.1299.   
(8aS*,10aR*)-3-Methyl-5,8a,9,10a-tetrahydro-6H-
2,10-dioxa-9-azaanthracen-1-one (13) 
A solution of compound 27 (0.04 mmol) in CH2Cl2 
containing 10 % trifluoroacetic acid was stirred at 40 
oC for 1 h.  The reaction solution was diluted with 20 
mL of water, basified with 10% aqueous ammonium 
hydroxide, and extracted with CH2Cl2 three times (10 
mL each).  The combined organic layers were washed 
with brine, dried (MgSO4), concentrated, and column 
chromatographed on silica gel using a 1:1 mixture of 
ethyl acetate and hexane as an eluant to give 
compound 13. 
13 
Yield: 9 mg (100%); white solids; mp 131–133 oC. 
1H NMR (400 MHz, CDCl3): δ = 5.86-5.80 (m, 1 H, 
＝CH), 5.82 (s, 1 H, ＝CH), 5.53–5.50 (m, 1 H, CH＝
), 4.48–4.40 (m, 1 H, CH-O), 3.87 (s, 1 H, CH-N), 
3.78 (bs, 1 H, NH), 2.06-2.34 (m, 3 H, CH2-CH2), 
2.17 (s, 3 H, CH3), 1.91-1.81 (m, 1 H, CH2). 
13C NMR (100 MHz, CDCl3): δ = 161.9, 152.0, 148.3, 
130.7, 126.7, 110.3, 100.6, 73.3, 47.4, 25.7, 22.1, 
19.5. 
MS (ESI, MeOH): m/z = 242.5 ([M + H]+). 
HRMS-ESI: m/z [M = Na]+ calcd for C12H13NO3Na: 
242.0793; found: 242.0775.   
(8R*,8aS*,10aR*)-8-Hydroxy-3-methyl-1-oxo-
5,6,7,8,8a,10a-hexahydro-1H-2,10-dioxa-9-
azaanthracene-9-carboxylic acid tert-butyl ester 
(28) 
To a solution of compound 27 (0.11 mmol) in dry 
THF (0.5 mL) at 0 oC under argon was added 
BH3•THF in tetrahydrofuran (1 M, 0.109 mmol) and 
the resulting solution was stirred at 25 oC for 18 h, 
cooled to 0 oC, and added with 30% hydrogen 
peroxide (1 mL) and 0.1% aqueous sodium hydroxide 
(1 mL).  The mixture was stirred for 10 min. at 0 oC 
followed by 3 h at 25 oC, diluted with water, and 
extracted four times with CH2Cl2 (10 mL each).  The 
combined organic layers were washed with brine, 
dried (MgSO4), concentrated, and column 
chromatographed on silica gel using a gradient 
mixture of hexane and ethyl acetate as eluant to give 
compound 28.  TLC and NMR spectral data indicate it 
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to be a single stereoisomer and 2D COSY and 
NOESY spectra show the hydroxyl function is cis to 
the angular hydrogens (C8a and C10a H’s). 
28 
Yield: 32 mg (87%); white solids; mp 162–163 oC. 
1H NMR (400 MHz, CDCl3): δ = 5.82 (s, 1 H, C4H), 
4.40 (q, J = 3 Hz, 1 H, C10aH), 4.22 (dd, J = 10.1, 3.5 
Hz, 1 H, C8aH), 3.33 (td, J = 10.5, 4.7 Hz, 1 H, C8H), 
2.90 (bs, 1 H, OH), 2.23 (s, 3 H), 2.18-2.06 (m, 2 H), 
1.72-1.63 (m, 2 H), 1.50 (s, 9 H), 1.50-1.38 (m, 2 H). 
13C NMR (100 MHz, CDCl3): δ = 160.7, 159.1, 156.0, 
153.9, 102.9, 99.4, 82.8, 76.6, 65.5, 57.4, 32.2, 29.9, 
28.2, 19.9, 18.4. 
2D-NOESY NMR (400 MHz, CDCl3): signal C4H (δ 
5.82) correlates with signal C3-Me (δ 2.23), signal 
C10aH (δ 4.40) correlates with signal C8aH (δ 4.22), 
and signal C8aH (δ 4.22) correlates with signal C8H 
(δ 3.33).  No correlation is found between signals 
C8H and C10aH. 
MS (ESI, MeOH): m/z = 360.5 ([M + Na]+). 
HRMS-ESI: m/z [M + Na]+ calcd for C17H23NO6Na: 
360.1423; found: 360.1411.   
(8R*,8aS*,10aR*)-8-Hydroxy-3-methyl-
5,7,8,8a,9,10a-hexahydro-6H-2,10-dioxa-9-
azaanthracen-1-one (14) 
A solution of compound 28 (0.065 mmol) in 2 mL of 
10% TFA in CH2Cl2 was stirred at 40 oC for 1 h, 
partitioned between CH2Cl2 (10 mL) and water (20 
mL), and basified using 10% aqueous NH4OH.  The 
organic layer was removed and the aqueous layer 
extracted three times with CH2Cl2 (10 mL each).  The 
combined organic layers were dried (MgSO4), filtered, 
and concentrated on a rotary evaporator to give a solid 
which was purified by column chromatography on 
silica gel (8:1 of ethyl acetate:hexane) to afford 
compound 14. 
14 
Yield: 10 mg (65%); white solids; mp 92–94 oC. 
1H NMR (400 MHz, CDCl3): δ = 5.81 (s, 1 H), 4.33 
(s, 1 H), 4.15 (bs, 1 H), 3.60-3.54 (m, 1 H), 3.21-3.19 
(m, 1 H), 2.19 (s, 3 H), 2.18-2.02 (m, 4 H), 1.43-1.32 
(m, 2 H). 
13C NMR (100 MHz, CDCl3): δ = 162.1, 152.1, 148.7, 
110.7, 100.7, 74.5, 67.6, 57.4, 32.6, 29.9, 19.4, 18.8. 
MS (ESI, MeOH): m/z = 260.3 ([M + Na]+). 
HRMS-ESI: m/z [M + Na]+ calcd for C12H15NO4Na: 
260.0899; found: 260.0884. 
(8aR*,10aR*)-3-Methyl-1,8-dioxo-5,6,7,8,8a,10a-
hexahydro-1H-2,10-dioxa-9-azaanthracene-9-
carboxylic acid tert-butyl ester (15) 
To a solution of compound 28 (0.024 mmol) in 
DMSO (0.5 mL) under argon was added 2-
iodoxybenzoic acid (IBX; 0.034 mmol), and the 
solution was stirred at 25 oC for 2 h.  Additional IBX 
(0.034 mmol) was added and the reaction mixture was 
stirred for 12 h after which the mixture was diluted 
with water (5 mL) and extracted three times with 
diethyl ether (10 mL each).  The combined organic 
layer was washed with brine, dried (MgSO4), and 
concentrated to give compound 15. 
15 
Yield: 7 mg (87%); white solids; mp 90–92 oC. 
1H NMR (400 MHz, CDCl3): δ = 5.69 (s, 1 H, C4H), 
5.20 (d, J = 4 Hz, 1 H, CHN), 4.75 (q, J = 4 Hz, 1 H, 
CHO), 2.54-1.85 (m, 6 H), 2.17 (s, 3 H), 1.50 (s, 9 H). 
13C NMR (100 MHz, CDCl3): δ = 201.1, 159.4, 158.8, 
155.0, 152.4, 104.5, 98.9, 83.2, 79.7, 60.4, 41.3, 29.5, 
28.2, 21.6, 19.8. 
MS (ESI, MeOH): m/z = 358.3 ([M + Na]+). 
HRMS-ESI: m/z [M + Na]+ calcd for C17H21NO6Na: 
358.1267; found: 358.1257. 
4-Hydroxy-3-(4-methoxybenzylamino)-6-methyl-
2H-pyran-2-one (29) 
A solution of compound 23 (1.42 mmol) and p-
anisaldehyde (1.42 mmol) in methanol (10 mL) was 
stirred at 25 oC for 12 h.  The reaction solution was 
concentrated to give intermediate compound 4-
hydroxy-3-(4-methoxybenzylideneamino)-6-methyl-
2H-pyran-2-one (0.37 g, 100% yield) as a yellow 
solid, which was used for the next step without further 
purification. To a solution the aforementioned imine 
(1.04 mmol) in ethanol (15 mL) was added sodium 
cyanoborohydride (1.25 mmol) and acetic acid (1.25 
mmol) at 25 oC.  After stirring for 30 min the solution 
was diluted with aqueous NaHCO3 (1.5 mmol) and 
concentrated to give a crude oil that was purified by 
column chromatography on silica gel using a 5% 
methanol in CH2Cl2 as an eluant to give compound 
29. 
29 
Yield: 0.24 g (89%); yellow solids; mp 179–181 oC. 
1H NMR (400 MHz, DMSO-d6): δ = 7.80 (bs, 2 H, 
NH, OH), 7.25 (d, J = 8.8 Hz, 2 H, Ar-H), 6.84 (d, J = 
8.8 Hz, 2 H, Ar-H), 5.61 (s, 1 H, ＝CH), 4.17 (s, 2 H, 
CH2N), 3.71 (s, 3 H, OCH3), 2.00 (s, 3 H, CH3). 
13C NMR (100 MHz, DMSO-d6): δ = 165.8, 161.6, 
158.9, 156.8, 130.6, 127.1, 113.5, 104.9, 101.5, 55.0, 
48.7, 19.1. 
MS (ESI, MeOH): m/z = 284.2 ([M + Na]+). 
HRMS-ESI: m/z [M + Na]+ calcd for C14H15NO4Na: 
284.0899; found: 284.0895. 
(8aS*,10aR*)-9-(4-Methoxybenzyl)-3-methyl-
7,8a,9,10a-tetrahydro-8H-2,10-dioxa-9-
azaanthracen-1-one (30) 
A solution of 20 mg (76 mol) of 29, 31 mg (0.13 
mmol) of trans-3,6-dibromocyclohexene (25), and 39 
L (0.28 mmol) of triethylamine in DMF (1 mL) was 
stirred at 80 oC under argon for 2.5 h. The reaction 
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mixture was diluted with 50 mL of ethyl acetate and 
washed three times with water (10 mL each), and 
brine, dried (MgSO4), concentrated, and column 
chromatographed on silica gel using a mixture of 30% 
ethyl acetate in hexane as eluant to give compound 30. 
30 
Yield: 13 mg (50%); pale yellow solids; mp 300oC 
(not melt). 
1H NMR (400 MHz, CDCl3): δ = 7.32 (d, J = 8.0 Hz, 
2 H, Ar-H), 6.86 (d, J = 8.0 Hz, 2 H, Ar-H), 6.04-5.97 
(m, 1 H, CH=), 5.96-5.90 (m, 1 H, CH=), 5.78 (s, 1 H,  
CH=), 4.49 (d, J = 12 Hz, 1 H, Ar-CH2N), 4.01 (d, J = 
12 Hz, 1 H, Ar-CH2N), 3.87 (t, J = 4 Hz, 1 H, CHO), 
3.81 (s, 3 H, Ar-OCH3), 3.02 (dt, J =  12, 4 Hz, 1 H, 
CHN), 2.21 (s, 3 H, CH3), 2.18-2.03 (m, 2 H, CH2), 
1.52-1.32 (m, 2 H, CH2). 
13C NMR (100 MHz, CDCl3): δ = 162.6, 159.1, 155.0, 
152.4, 135.5, 130.5, 130.4, 123.8, 113.9, 111.1, 100.4, 
66.3, 56.5, 55.4, 53.4, 26.4, 22.6, 19.6. 
2D COSY NMR (400 MHz, CDCl3): signal (δ 6.04-
5.97 ppm; =CH) correlates with signal (δ 5.96-5.90 
ppm; =CH), signal (δ 6.04-5.97 ppm; =CH) correlates 
with signal (δ 2.18-2.03 ppm), signal (δ 2.18-2.03 
ppm) correlates with signal (δ 1.52-1.32 ppm), signal 
(δ 1.52-1.32 ppm) correlates with signal (δ 3.02 ppm, 
CHN), and signal (δ 3.02 ppm) correlates with signal 
(δ 3.87 ppm, CHO). 
MS (ESI, MeOH): m/z = 362.2 ([M + Na]+). 
HRMS-ESI: m/z [M + Na]+ calcd for C20H21NO4Na: 
362.1368; found 362.1360. 
(8aS*,10aR*)-3-Methyl-7,8a,9,10a-tetrahydro-8H-
2,10-dioxa-9-azaanthracen-1-one (16) 
A solution of 30 (17.7 mol) and TFA (1 drop) in 
CH2Cl2 (1 mL) was heated at refluxed for 12 h under 
argon, cooled to 25 oC, diluted with saturated aqueous 
NaHCO3, and extracted three times with CH2Cl2.  The 
combined organic layer was washed with brine, dried 
(MgSO4), concentrated, and column chromatographed 
on silica gel using 20% ethyl acetate in hexane as an 
eluant to afford compound 16. 
Yield: 2.3 mg (59%); white solids; mp 134–136 oC. 
1H NMR (400 MHz, CDCl3): δ = 5.97 (dt, J = 10.0, 
3.6 Hz, 1 H, CH＝), 5.82 (s, 1 H, ＝CH), 5.81-5.70 
(m, 1 H, CH＝), 4.61 (s, 1 H, CHO), 3.76 (s, 1 H, 
NH), 3.63-3.50 (m, 1 H, CHN), 2.40-2.27 (m, 1 H, 
CH2), 2.18 (s, 3 H, CH3), 2.18-2.10 (m, 1 H, CH2), 
1.94-1.68 (m, 2 H, CH2). 
13C NMR (100 MHz, CDCl3): δ = 161.8, 151.1, 145.7, 
133.3, 124.4, 111.8, 100.7, 71.3, 47.5, 25.4, 23.5, 
19.3. 
MS (ESI, MeOH): m/z = 242.6 ([M + Na]+). 
HRMS-ESI: m/z [M + Na]+ calcd for C12H13NO3Na: 
242.0793; found: 242.0776. 
(8aS*,10aR*)-3-Methyl-7,8,8a,9,10a-tetrahydro-8H-
2,10-dioxa-9-azaanthracen-1-one (16).  From a one-
step method 
A solution of 23 (3.54 mmol), trans-3,6-
dibromocyclohexene (25; 4.25 mmol), and 
triethylamine (8.85 mmol) in DMF (35 mL) was 
stirred at 120 oC under argon for 2 h, cooled to 25 oC, 
diluted with saturated aqueous NaHCO3, and 
extracted three times with CH2Cl2.  The combined 
organic layer was dried (MgSO4), concentrated, and 
column chromatographed on silica gel using 10% 
ethyl acetate in hexane as an eluant to give compound 
16. 
Yield: 99 mg (13%) white solids.   
The spectral data are identical to that described in the 
previous experiment. Slow evaporation of a solution 
of 16 in ethanol provided single crystals which were 
used for X-ray analysis.  
Supporting Information for this article is available 
online at http://www.thieme-
connect.com/ejournals/toc/synthesis.  
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